Skip to main content
Premium Trial:

Request an Annual Quote

TGen, Mayo, and Scottsdale to Build $25M Facility

NEW YORK, Dec. 5 (GenomeWeb News) - The city of Scottsdale, Ariz. announced yesterday that it was partnering with the Translational Genomics Research Institute and the Mayo Clinic to start a $25 million research facility as part of Arizona's push to pull in biotech industry.


TGen is seeking $3 million from the city to help start the plant, which would open at the end of 2004 if approved by the Scottdale city council, according to a local report from the ArizonaRepublic. If TGen gets the $3 million, it will house its Center for Translational Drug Development in the new building. Mayo and other leasing companies would use the other parts of the building.


The city council will decide next Tuesday on whether it will provide the $3 million in funding.


The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.